Q4 2025 earnings call: revenue, margin, cash, and 2026 outlook with FDA-submitted STI launches and Africa expansion—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results